In cases where the DMD variant is pathogenic and clinical assessment supports a diagnosis of dystrophinopathy, this may explain the patient’s symptoms if they are known to be associated with dystrophinopathy. Here, DMD is linked to neuromuscular disease caused by qualitative or quantitative defects of dystrophin.